Founder/CEO Amogha Tadimety
Hanover, NH
2022 MBA Northeast
LinkedIn | Website

Molecular diagnostics company disrupting traditional testing methodologies for women.

Press Release

Nanopath raises a $10M Series A months after VCIC

Nanopath, a Cambridge, Mass.-based women's health diagnostics company, raised $10m in Series A funding. Norwest Venture Partners and the Medtech Convergence Fund co-led, and were joined by Gingerbread Capital and Green D Ventures.
Press Release